検索結果

ion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer severe visual impairment, resulting in less than 0.1 in decimal visual acuity(1) . However, n...

ion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer severe visual impairment, resulting in less than 0.1 in decimal visual acuity 1) . However, n...

Research and Development System | Research & Development | SENJU Pharmaceutica

agement method based on our strong desire to "deliver drugs as quickly as possible to patients suffering from eye diseases." "First in Class products" in our vision is defined as &...

ion leads to irreversible impairment of visual field and vision loss. Approximately 90% of patients suffer severe visual impairment, resulting in less than 0.1 in decimal visual acuity 1) . However, n...